Application
Western blot analysis of FUCA2 Antibody in A2058 cell line lysates (35ug/lane). FUCA2 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with FUCA2 Antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | FUCA2 Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | FUCA2; Plasma alpha-L-fucosidase; Alpha-L-fucoside fucohydrolase 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | FUCA2 Plasma alpha-L-fucosidase Alpha-L-fucoside fucohydrolase 2 |
|---|---|
| Molecular Weight(MW) | 54067 Da |
| Function | Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-linked fucose joined to the reducing-end N- acetylglucosamine of the carbohydrate moieties of glycoproteins |
| Tissue Specificity | This FUCA2 antibody is generated from rabbits immunized with human FUCA2 recombinant protein. |
| Cellular Localization | Secreted (Probable). |
| Entrez Gene | 2519 |
|---|
Application
Western blot analysis of FUCA2 Antibody in A2058 cell line lysates (35ug/lane). FUCA2 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with FUCA2 Antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
